1. Davis, B. H., Holden, J. T., Bene, M. C., et al. (2007) 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin. Cytom.
72, Suppl 1, S5–S13.
2. Stetler-Stevenson, M., Ahmad, E., Barnett, D., et al. (2007) Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline – Second Edition. Clinical and Laboratory Standards Institute
27, Wayne, PA, USA.
3. Wood, B. L., Arroz, M., Barnett, D., DiGiuseppe, J., Greig, B., Kussick, S. J., Oldaker, T., Shenkin, M., Stone, E., and Wallace, P. (2007) 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin. Cytom.
72, Suppl 1, S14–S22.
4. Stelzer, G. T., Marti, G., Hurley, A., McCoy, P., Jr., Lovett, E. J., and Schwartz, A. (1997) U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry
30, 214–230.
5. Swerdlow, S. H., Campo, E., Harris, N. L., et al. (2008) WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, Forth Edition, International Agency for Research on Cancer (IARC), Lyon, France.